{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000012989", "version": 24, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "1996-11-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a Dutch family in which autosomal dominant diabetes insipidus (125700) could be traced back for 5 generations, Bahnsen et al. (1992) identified a G-to-T transversion within the neurophysin-encoding exon B, which converted a highly conserved glycine (gly17 of neurophysin) to a valine residue."}, "citations": [{"ids": [{"source": "PubMed", "value": "1740104"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Olias et al. (1996) examined whether this point mutation affects the processing and transport of the vasopressin-neurophysin precursor. They stably expressed the normal and mutant vasopressin cDNAs under the control of the cytomegalovirus promoter in the mouse pituitary cell line AtT20. The mutant precursor was synthesized, but processing and secretion were dramatically reduced compared to the normal. The mutant neurophysin staining was restricted to the endoplasmic reticulum and never reached the trans-Golgi network, whereas the normal neurophysin concentrated in the tips of the cell processes where secretory granules accumulate. These results suggested that the mutation alters the conformation of the precursor, impairs its intracellular transport, and triggers its retention."}, "citations": [{"ids": [{"source": "PubMed", "value": "8945633"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000012205", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_000490.5(AVP):c.143G>T (p.Gly48Val)"}}, {"value": {"type": "Alternate", "value": "G17V"}, "xrefs": [{"db": "OMIM", "id": "192340.0002", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000020.11:3083155:C:A", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_715t1:c.143G>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_000490.5:c.143G>T"}, {"type": "HGVS, genomic, LRG", "value": "LRG_715:g.6569G>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_008663.1:g.6569G>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000020.11:g.3083156C>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000020.10:g.3063802C>A"}, {"type": "HGVS, protein", "value": "LRG_715p1:p.Gly48Val"}, {"type": "HGVS, protein", "value": "P01185:p.Gly48Val"}, {"type": "HGVS, protein, RefSeq", "value": "NP_000481.2:p.Gly48Val"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_000490.5:c.143G>T"}]}, {"type": "ProteinChange1LetterCode", "value": "G48V"}, {"type": "ProteinChange3LetterCode", "value": "GLY17VAL"}], "sequence_location": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 3083156, "stop": 3083156, "display_start": 3083156, "display_stop": 3083156, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 3083156, "reference_allele_vcf": "C", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 3063802, "stop": 3063802, "display_start": 3063802, "display_stop": 3063802, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 3063802, "reference_allele_vcf": "C", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "arginine vasopressin"}}], "symbols": [{"value": {"type": "Preferred", "value": "AVP"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 3082556, "stop": 3084724, "display_start": 3082556, "display_stop": 3084724, "strand": "-", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 3063201, "stop": 3065369, "display_start": 3063201, "display_stop": 3065369, "strand": "-", "variant_length": 2169, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "551"}, {"db": "OMIM", "id": "192340", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:894"}]}], "xrefs": [{"db": "UniProtKB", "id": "P01185#VAR_004984"}, {"db": "OMIM", "id": "192340.0002", "type": "Allelic variant"}, {"db": "dbSNP", "id": "121964883", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_000490.5(AVP):c.143G>T (p.Gly48Val)"}}], "xrefs": [{"db": "ClinGen", "id": "CA121948"}], "id": 12205}, "trait_set": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Neurohypophyseal diabetes insipidus"}, "xrefs": [{"db": "Genetic Alliance", "id": "Neurogenic+diabetes+insipidus/5185"}, {"db": "Human Phenotype Ontology", "id": "HP:0000863"}, {"db": "MONDO", "id": "MONDO:0007450"}, {"db": "SNOMED CT", "id": "45369008"}]}, {"value": {"type": "Alternate", "value": "Pituitary diabetes insipidus"}}, {"value": {"type": "Alternate", "value": "Diabetes insipidus cranial type"}}, {"value": {"type": "Alternate", "value": "Diabetes Insipidus, Neurogenic"}}, {"value": {"type": "Alternate", "value": "DIABETES INSIPIDUS, PRIMARY CENTRAL"}, "xrefs": [{"db": "OMIM", "id": "125700", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "Hereditary central diabetes insipidus"}, "xrefs": [{"db": "Orphanet", "id": "30925"}]}], "symbols": [{"value": {"type": "Alternate", "value": "CDI"}, "xrefs": [{"db": "OMIM", "id": "125700", "type": "MIM"}]}], "attributes": [{"value": {"type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "6015"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0007450"}, {"db": "MedGen", "id": "C0342394"}, {"db": "Orphanet", "id": "178029"}, {"db": "Orphanet", "id": "30925"}, {"db": "OMIM", "id": "125700", "type": "MIM"}]}], "id": 8098}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 70492}, "record_status": "current", "title": "NM_000490.5(AVP):c.143G>T (p.Gly48Val) AND Neurohypophyseal diabetes insipidus", "clinvar_assertions": [{"id": 33234, "clinvar_submission_id": {"local_key": "192340.0002_DIABETES INSIPIDUS, NEUROHYPOPHYSEAL", "submitter": "OMIM", "title": "AVP, GLY17VAL_DIABETES INSIPIDUS, NEUROHYPOPHYSEAL", "submitter_date": "2012-03-02"}, "clinvar_accession": {"acc": "SCV000033234", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "1996-11-01"}], "external_ids": [{"db": "OMIM", "id": "192340.0002", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a Dutch family in which autosomal dominant diabetes insipidus (125700) could be traced back for 5 generations, Bahnsen et al. (1992) identified a G-to-T transversion within the neurophysin-encoding exon B, which converted a highly conserved glycine (gly17 of neurophysin) to a valine residue."}, "citations": [{"ids": [{"source": "PubMed", "value": "1740104"}]}], "xrefs": [{"db": "OMIM", "id": "125700", "type": "MIM"}]}, {"attribute": {"type": "Description", "value": "Olias et al. (1996) examined whether this point mutation affects the processing and transport of the vasopressin-neurophysin precursor. They stably expressed the normal and mutant vasopressin cDNAs under the control of the cytomegalovirus promoter in the mouse pituitary cell line AtT20. The mutant precursor was synthesized, but processing and secretion were dramatically reduced compared to the normal. The mutant neurophysin staining was restricted to the endoplasmic reticulum and never reached the trans-Golgi network, whereas the normal neurophysin concentrated in the tips of the cell processes where secretory granules accumulate. These results suggested that the mutation alters the conformation of the precursor, impairs its intracellular transport, and triggers its retention."}, "citations": [{"ids": [{"source": "PubMed", "value": "8945633"}]}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "AVP, GLY17VAL"}}], "attributes": [{"type": "NonHGVS", "value": "GLY17VAL"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "AVP"}}]}], "xrefs": [{"db": "OMIM", "id": "192340.0002", "type": "Allelic variant"}]}]}, "trait_set": [{"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "DIABETES INSIPIDUS, NEUROHYPOPHYSEAL"}}]}]}]}]}
